Belviq

Product NDC: 62856-529
11-digit product format: 628560529
Labeler code: 62856
Product ID: 62856-529_56a5ecbb-948c-4dda-b6ce-6b0086f2e293
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lorcaserin hydrochloride hemihydrate
Dosage form: TABLET
Route: ORAL
Labeler: Eisai Inc.
Application: NDA022529
Marketing category: NDA
Marketing start: 2012-06-27
Marketing end: 2022-04-30
Substance: LORCASERIN HYDROCHLORIDE HEMIHYDRATE
Active strength: 10 mg/1
Pharmacologic classes: Serotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
62856-529-60	EA - Each	62856-529	f8fbcae7-4b18-4551-9a56-36746cf8c3bd	1	2013-03-03

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
REV26SR2B4	LORCASERIN HYDROCHLORIDE HEMIHYDRATE	856681-05-5	LORCASERIN HYDROCHLORIDE HEMIHYDRATE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
62856-529-60	62856052960	60 TABLET in 1 BOTTLE (62856-529-60)	60 tablet	2012-06-27	2022-04-30	No	No	Current